@Davisite Regarding pre LVAD ischemics you are right…but the statement today is regarding end stage heart patients with LVADs . A further pre BLA meeting will clarify FDA expectations for an accelerated approval filing …there is no requirement as far as I am aware for an additional trial before an accelerated approval decision in the latter indication. I was not expecting such a good outcome….so I am genuinely surprised that the FDA appears to have finally agreed on the MOA and potency for this indication. If the FDA minutes said something different to what has been reported Silviu would be open to massive lawsuits…so i feel very confident in my interpretation. To be honest , it’s in black and white in the statement so i should be telling the shorters to go where the light doesn’t shine …OP
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-125
-
-
- There are more pages in this discussion • 425 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 0.935 |
12 | 175098 | 0.930 |
7 | 101559 | 0.925 |
8 | 126323 | 0.920 |
10 | 99179 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 14089 | 2 |
0.950 | 32015 | 3 |
0.955 | 49989 | 4 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online